Report - GFO: incretinetherapie bij T2DM · MET+SU Exenatide MET, MET+SU Dulaglutide MET±(1-2 OAD), SU±(1-2 OAD) Semaglutide MET±SU) Verandering gewicht: GLP-1 ra vs basale insuline Insuline

Please pass captcha verification before submit form